Roberta Beverly Gerson, DO | |
2 Livewell Dr, Goodall Occupational Health Center, Kennebunk, ME 04043-6762 | |
(207) 490-7801 | |
(207) 604-1018 |
Full Name | Roberta Beverly Gerson |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 2 Livewell Dr, Kennebunk, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023176823 | NPI | - | NPPES |
1232 | Other | ME | STATE LICENSE NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 1232 (Maine) | Primary |
207Q00000X | Family Medicine | 1232 (Maine) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Roberta Beverly Gerson, DO 459 Pool St, Biddeford, ME 04005-9575 Ph: (207) 282-9008 | Roberta Beverly Gerson, DO 2 Livewell Dr, Goodall Occupational Health Center, Kennebunk, ME 04043-6762 Ph: (207) 490-7801 |
News Archive
Researchers from University of California, Irvine have found the key responses of brain cells to Alzheimer's disease (AD) and say that this could help them understand the chronic debilitating and progressive neurodegenerative disease better in future.
Inovio Pharmaceuticals, Inc. today announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the global industry as judged by a panel of global biotech industry stakeholders.
ProtekMed has launched the Tru-flo(TM) urinary catheter valve, an innovative and economical alternative to the standard tube and bag system prescribed by most urologists today.
In a clear victory for public health, a federal judge in Kentucky today rejected a motion by tobacco companies to block key provisions of the new law giving the U.S. Food and Drug Administration (FDA) the power to regulate tobacco products. Specifically, today's decision strongly supports the government's authority to prevent the industry from making health claims about its products without FDA approval.
After leaving ACA's Office of Consumer Information and Insurance Oversight this year, Jay Angoff has remained a senior adviser to Health and Human Services Secretary Kathleen Sebelius. ... Q: How did politics make it difficult for you to implement ACA? Angoff: The hard part had nothing to do with politics.
› Verified 7 days ago